<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>) is a B-cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> characterized by a monoclonal proliferation of lymphocytes with the co-expression of CD5 and CD43, but not of CD23 </plain></SENT>
<SENT sid="1" pm="."><plain>Typical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> is associated with overexpression of cyclin D1, and blastoid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> variants are associated with Myc (alias c-myc) translocations </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we developed a murine model of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>-like <z:hpo ids='HP_0002665'>lymphoma</z:hpo> by crossing Cdk4(R24C) mice with Myc-3'RR transgenic mice </plain></SENT>
<SENT sid="3" pm="."><plain>The Cdk4(R24C) mouse is a knockin strain that expresses a Cdk4 protein that is resistant to inhibition by p16(INK4a) as well as other INK4 family members </plain></SENT>
<SENT sid="4" pm="."><plain>Ablation of INK4 control on Cdk4 does not affect <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e>, B-cell maturation, and functions in Cdk4(R24C) mice </plain></SENT>
<SENT sid="5" pm="."><plain>Additionally, B cells were <z:mpath ids='MPATH_458'>normal</z:mpath> in numbers, cell cycle activity, <z:chebi fb="0" ids="52290">mitogen</z:chebi> responsiveness, and Ig synthesis in response to activation </plain></SENT>
<SENT sid="6" pm="."><plain>By contrast, breeding Cdk4(R24C) mice with Myc-3'RR transgenic mice prone to develop aggressive Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-like <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (CD19(+)IgM(+)IgD(+) cells) leads to the development of clonal blastoid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>-like <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (CD19(+)IgM(+)CD5(+)CD43(+)CD23(-) cells) in Myc/Cdk4(R24C) mice </plain></SENT>
<SENT sid="7" pm="."><plain>Western blot analysis revealed high amounts of Cdk4/cyclin D1 complexes as the main hallmark of these <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>These results indicate that although silent in nonmalignant B cells, a defect in the INK4-Cdk4 checkpoint can participate in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> in conjunction with additional alterations of cell cycle control, a situation that might be reminiscent of the development of human blastoid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
</text></document>